BCM
BSX icon

Blume Capital Management’s Boston Scientific BSX Stock Holding History

Blume Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9
Closed -$967 – 363
2025
Q2 		$967 Hold
9
– – ﹤0.01% 362
2025
Q1 		$908 Buy
+9
New +$906 ﹤0.01% 371
2018
Q2 		– Sell
-100
Closed -$2K – 199
2018
Q1 		$2K Hold
100
– – ﹤0.01% 209
2017
Q4 		$2K Buy
+100
New +$2.76K ﹤0.01% 222

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Blume Capital Management's BSX Position: Q3 2025 in Review

Blume Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 9 shares — an estimated $967 sold.

Blume Capital Management first reported a position in BSX in Q4 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2018. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Blume Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Blume Capital Management sold 9 Boston Scientific shares in Q3 2025, an estimated $967.
  • Blume Capital Management first reported a position in Boston Scientific in Q4 2017 and held it in 4 quarters.
  • Blume Capital Management's Boston Scientific position peaked at $2K in Q1 2018.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Blume Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.